The Association for Molecular Pathology says it “is very concerned and disappointed” about the FDA’s letter to the Texas developers of a molecular test that can detect Zika virus-specific RNA sequences in a large metropolitan area. “Given the ongoing outbreak of the infection and risk of infection in the Houston area, these types of tests […]
